通过知识图集集成增加罕见疾病数据集的可发现性
Ian Braun1, Emily Hartley1, Daniel Olson1
1Data Collaboration Center, Critical Path Institute, Tucson, AZ 85718, United States.
JAMIA open
|February 10, 2025
概括
这项研究通过将患者数据与生物学关联结合起来,提高了罕见病数据集的可发现性. 这创建了一个知识图 (KG),用于改进语义搜索和数据总结.
科学领域:
- 生物信息学是一种生物信息学.
- 数据科学数据科学数据科学
- 医疗信息学 医疗信息学
背景情况:
- 由于数据碎片化,发现罕见疾病数据集具有挑战性.
- 现有的知识图缺乏全面的患者数据集成.
- 提高数据可发现性对于罕见疾病研究至关重要.
研究的目的:
- 开发一种方法来提高罕见疾病数据集的可发现性.
- 用生物学关联来丰富源数据.
- 为患者数据集创建一个语义搜索界面.
主要方法:
- 扩展了Biolink的语义模型,包括患者数据.
- 创建了一个知识图 (KG),整合了患者数据和生物实体.
- 利用现有的映射和映射标准进行数据集成.
主要成果:
- 开发了一个丰富的患者数据模型.
- 创建了一个知识图 (KG) 与患者数据和生物关联.
- 启用了一个具有生物上下文意识的搜索应用程序.
结论:
- 该方法通过丰富数据与生物知识来提高数据集的可发现性.
- 该方法为模拟源数据提供了一个框架,以增强自然语言查询.
- 用条件概念说明的技术可以应用于其他数据实体.
相关概念视频
Genomics
35.7K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
35.7K
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K


